Shah VP - Search Results

1

Biowaiver monographs for immediate release solid oral dosage forms: rifampicin.

Becker C, Dressman JB, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM. Becker C, et al. Among authors: shah vp. J Pharm Sci. 2009 Jul;98(7):2252-67. doi: 10.1002/jps.21624. J Pharm Sci. 2009. PMID: 19160441

2

Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.

Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD, et al. Shah VP, et al. Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):249-55. doi: 10.1007/BF03189968. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1823867

3

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.

Skelley JP, Amidon GL, Barr WH, Benet LZ, Carter JE, Robinson JR, Shah VP, Yacobi A. Skelley JP, et al. Among authors: shah vp. J Pharm Sci. 1990 Sep;79(9):849-54. doi: 10.1002/jps.2600790923. J Pharm Sci. 1990. PMID: 1980308 No abstract available.

4

Evaluation of orally administered highly variable drugs and drug formulations.

Shah VP, Yacobi A, Barr WH, Benet LZ, Breimer D, Dobrinska MR, Endrenyi L, Fairweather W, Gillespie W, Gonzalez MA, Hooper J, Jackson A, Lesko LJ, Midha KK, Noonan PK, Patnaik R, Williams RL. Shah VP, et al. Pharm Res. 1996 Nov;13(11):1590-4. doi: 10.1023/a:1016468018478. Pharm Res. 1996. PMID: 8956322 Review. No abstract available.

5

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms.

Dressman JB, Amidon GL, Reppas C, Shah VP. Dressman JB, et al. Among authors: shah vp. Pharm Res. 1998 Jan;15(1):11-22. doi: 10.1023/a:1011984216775. Pharm Res. 1998. PMID: 9487541 Free article. Review.

6

Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.

Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL. Shah VP, et al. Pharm Res. 1998 Feb;15(2):167-71. doi: 10.1023/a:1011941929495. Pharm Res. 1998. PMID: 9523299 Free article. No abstract available.

7

Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability.

Meyer MC, Straughn AB, Jarvi EJ, Patrick KS, Pelsor FR, Williams RL, Patnaik R, Chen ML, Shah VP. Meyer MC, et al. Among authors: shah vp. Pharm Res. 2000 Apr;17(4):381-4. doi: 10.1023/a:1007560500301. Pharm Res. 2000. PMID: 10870979 Clinical Trial.

8

Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide.

Löbenberg R, Krämer J, Shah VP, Amidon GL, Dressman JB. Löbenberg R, et al. Among authors: shah vp. Pharm Res. 2000 Apr;17(4):439-44. doi: 10.1023/a:1007529020774. Pharm Res. 2000. PMID: 10870988 Free article.

9

Bioanalytical method validation--a revisit with a decade of progress.

Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Shah VP, et al. Pharm Res. 2000 Dec;17(12):1551-7. doi: 10.1023/a:1007669411738. Pharm Res. 2000. PMID: 11303967 Clinical Trial. No abstract available.

10

Bioavailability and bioequivalence: an FDA regulatory overview.

Chen ML, Shah V, Patnaik R, Adams W, Hussain A, Conner D, Mehta M, Malinowski H, Lazor J, Huang SM, Hare D, Lesko L, Sporn D, Williams R. Chen ML, et al. Pharm Res. 2001 Dec;18(12):1645-50. doi: 10.1023/a:1013319408893. Pharm Res. 2001. PMID: 11785681 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters